Medical Societies Back New Respiratory Vaccine Guidance - EMJ

Medical Societies Unify on Vaccine Guidance

Four leading medical societies have unanimously endorsed unified respiratory vaccine guidance for the 2026–2027 virus season.

The joint endorsement covers influenza, respiratory syncytial virus (RSV), and COVID-19 vaccination recommendations for both adults and children. Among the groups involved are the Society of Critical Care Medicine (SCCM), the American College of Chest Physicians (CHEST), the American Academy of Allergy, Asthma & Immunology (AAAAI), and the American Thoracic Society (ATS).

Medical groups issue fall vaccine guidance as respiratory virus season approaches

Following procedural shifts made by the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) in 2025, the multi-society Vaccine Guidance Review Panel was established. According to the participating organizations, those regulatory updates produced potentially harmful modifications to vaccination schedules, prompting professional groups to step in and secure evidence-based consistency.

To restore clinical clarity, the panel reviewed and endorsed recommendation protocols from four major medical organizations. Those include the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, and the Infectious Diseases Society of America.

Instagram

The panel reached a working consensus aligned directly with ACIP recommendations issued before June 2025. Clinicians treating patients with chronic lung conditions face many complications, making unified professional positioning essential for routine patient care.

Michelle Ng Gong, ATS President, noted the practical necessity of these unified standards during national policy shifts.

Medical Societies Back New Respiratory Vaccine Guidance - EMJ — Photo: News-Medical

Clinicians and their patients with serious lung disease should not have to navigate a labyrinth of confusion, particularly as we face the upcoming respiratory virus season. The evidence-based vaccine recommendations endorsed by ATS, AAAAI, CHEST and SCCM provide clinicians with confidence and practical vaccine guidance when treating patients at the highest risk of severe illness, said Michelle Ng Gong, MD, ATSF, ATS President.

The collaboration provides frontline physicians with a reliable framework to discuss preventive care and coordinate treatment across pediatric and critical care specialties. Leaders from participating organizations emphasized that reducing seasonal risk requires routine outpatient visits and intensive care units to work together.

AAAAI strongly supports the adoption of evidence-based vaccine recommendations that help health care professionals make informed decisions and provide the best possible care for their patients, said AAAAI President Carla Davis, MD.

The participating societies intend to maintain this coordinated inter-specialty approach to vaccine education.

Medical groups issue guidance on fall vaccines

Additional Leadership Perspectives on Preventive Medicine

Leaders from the collaborating organizations highlighted the bedside impact of the unified guidance.

The work we are doing at the bedside is infinitely more effective when supported by a foundation of preventative medicine, said American College of Chest Physicians President Neil Freedman, MD. AAAAI President Carla Davis

Critical care leadership similarly emphasized the clinical realities observed during seasonal surges.

Fall vaccine guidance: What experts recommend for flu, RSV, and COVID-19

We strongly support the influenza, RSV, and COVID-19 vaccination recommendations from the AAP, ACOG, AAFP, and IDSA, said SCCM President Cherylee W. J. Chang, MD.